Please login to the form below

Not currently logged in
Email:
Password:

Proteostasis

This page shows the latest Proteostasis news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Meanwhile, Biogen licensed rights to a tau-targeting compound in development at Eisai for Alzheimer's in March, while Astellas signed a $1.2bn agreement with Proteostasis Therapeutics last November that

Latest news

  • Astellas earmarks up to $1.2bn for protein folding research Astellas earmarks up to $1.2bn for protein folding research

    Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed

  • Eisai forms neurology partnership with UCL Eisai forms neurology partnership with UCL

    The two organisations also announced in May, 2011, they would be stepping up their efforts into neurodegenerative disease, including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.

  • Eastern Europe targeted

    Licence. 83. Proteostasis/Elan. Discovery of disease-modifying small molecules for the treatment of neurodegenerative disorders.

  • Eisai/ UCL partnership grows

    The new phase will see the Eisai and UCL engage in joint research in neurodegenerative disease including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.

  • Elan and Proteostasis partnership

    There will also be an opportunity for Proteostasis to receive an additional $30m in collaboration funding over the next five years. ... Elan will become a 24 per cent shareholder in Proteostasis and will have the right of first negotiation to license

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Proteostasis Therapeutics strengthens leadership team Proteostasis Therapeutics strengthens leadership team

    Proteostasis Therapeutics strengthens leadership team. James DeTore, Geoffrey Gilmartin and Marija Zecevic join. ... Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics